ABSTRACT
INTRODUCTION
Anthracosis (greek, Άνθραξ read anthrax = coal; οσισ read osis = condition), also called 'black lung disease', is a chronic lung disease caused by accumulation of carbon pigment from breathing dirty air. 1 It is characterised by formation of black nodules on the bronchioles, focal emphysema, and the deposition of coal dust in lymph nodes ( Figure 1 ). 2 Since anthracosis is a form of pneumoconiosis not only caused by the occupational exposure to coal dust (coal workers pneumoconiosis), but also by cigarette smoking and environmental pollution, 3 radiologists should be aware of mediastinal lymph node enlargement occurring in these conditions, as this fact may impact staging of malignant lung diseases per se. To our knowledge, computed tomography (CT) appearance of histologically proven lymph node anthracosis has not been substantially addressed in the literature so far.
The aim of this retrospective analysis was to demonstrate CT findings of endobronchial ultrasoundguided transbronchial needle aspiration (EBUS-TBNA)-proven hilar and mediastinal lymph node anthracosis.
METHODS
We retrospectively researched the archives of our radiological and pulmonary departments to identify 49 patients (37 males, 12 females) with EBUS-TBNAconfirmed diagnosis of lymph node anthracosis between May 2009 and April 2012. Their median age was 66 years (range, 29-88 years). EBUS-TBNA revealed 89 anthracotic lymph nodes. All patients had undergone both chest X-ray and CT examinations. Abnormal findings in conventional chest X-ray (suspected pulmonary mass, lymph node enlargement, drug-refractory pneumonia) were the most common indications for performing chest CT (n=76/89, 85.4%). In addition, CT was performed for staging or restaging of tumours in 13 (14.6%) cases.
Multidetector CT (MDCT) examinations were carried out using a Siemens Somatom 64 (Siemens Medical Solutions, Forchheim, Germany) or Toshiba Aquilion 64 (Toshiba Medical Systems, Tokyo, Japan) CT system. Images were obtained at full inspiration using a 64 x 0.75 mm slice collimation with a tube voltage of 120 kV. The tube current (mA) was adjusted in relation to patient attenuation by means of the Care Dose modus (Siemens Medical Solutions) or the Sure Exposure modus (Toshiba Medical Systems). The reconstruction slice thickness was 3 to 5 mm in axial, coronal, and sagittal orientation. During MDCT, 100 to 120 ml of 300 mg or 400 mgI/l contrast medium was generally administered intravenously at a rate of 2 to 3 ml/s with a power injector followed by a normal saline 'chaser'.
Retrospective evaluation of the CT examinations was performed consensually by two board-certified radiologists (JK, RK). Mediastinal and hilar lymph node evaluation comprised measurement of diameter (short axis and long axis); lymph node enlargement was defined as showing a diameter of more than 7 to 11 mm on the short axis, depending on the regional nodal station, according to Glazer et al. 4 Enlarged lymph nodes were assessed for their density (prevalence of calcification or central low density as a sign of fatty involution), shape (oval, round, polycyclic), and contour (sharp, ill-defined). The presence of lymph node necrosis and noticeable contrast enhancement was documented. Nodal necrosis was considered present when an enlarged lymph node showed ill-defined lowattenuation areas. Noticeable lymph node enhancement was determined by nodal density of >60 HU on CT. The site of enlarged lymph nodes was documented on a standardised protocol according to the regional lymph node classification of the American Thoracic Society.
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EBUS-TBNA was performed with the patient under sedation or under general anaesthesia, as previously described. 6 A linear array 7.5-MHz ultrasonic bronchoscope (CP EBUS, Olympus Medical Systems, Tokyo, Japan) with a 90° angle of view was introduced orally or through an intubation tube. After ultrasound identification of a suspicious lymph node, transbronchial needle aspiration was performed using a 22G needle (model NA 201 SX 402, Olympus Medical Systems, Tokyo, Japan) under real-time ultrasound guidance. The aspirated material was prepared on glass slides, airdried and stained.
Descriptive data were presented as medians with ranges, if appropriate; categorical data were given as counts and percentages. Statistical analysis was performed with a specialised computer algorithm (MedCalc version 6, MedCalc Software).
The study was approved by the ethics committee of our university and was HIPAA (Health Insurance Portability and Accountability Act) compliant.
RESULTS
In the 49 enrolled patients with EBUS-TBNA-proven lymph node anthracosis, chest CT revealed 443 lymph nodes of which 169 (38.1%) were enlarged (Table) . Frequently enlarged lymph nodes were found in the American Thoracic Society (ATS) region 7 (n = 34); the highest percentage of lymph node enlargement was identified in region 11R (69.7%).
EBUS-TBNA revealed 89 anthracotic lymph nodes (Figure 2 ). The preferred localisation of transbronchial needle aspiration were: ATS region 7 (n=35/64 documented lymph nodes; 54.7%) and 10R (n=19/41; 46.3%). As a consequence, some non-enlarged lymph nodes were also aspirated in these regions. Lymph nodes in regions 2R (n=3/73; 4.1%), 2L (n=1/23; 4.3%), and 10L (n=2/33; 6.1%) were aspirated significantly less often. Despite the considerable size of enlarged lymph nodes measuring up to 26 mm in diameter, lymph nodes in region 5 were not examined.
Computed Tomographic Findings
A total of 52/89 (58.4%) cytologically proven anthracotic lymph nodes showed enlargement following the recommendations of Glazer et al. 4 The short axis of the anthracotic lymph nodes ranged from 5 to 23 mm in diameter, with a mean diameter of 11.1 mm (median, 11 mm). The long axis ranged from 6 to 33 mm, with a mean diameter of 16.5 mm (median, 16 mm Figure 4 ). Only two of the anthracotic lymph nodes showed a central hypodensity due to fatty involution (2.2%); none showed necrosis. Contrast enhancement was documented in 5/89 (5.6%) of the anthracotic lymph nodes.
DISCUSSION
Today, CT and positron emission tomography (PET) are the standard investigations for the assessment of hilar and mediastinal lymph nodes. 7 In general, lymph nodes with a short axis diameter of >10 mm are suspected to be malignant. Alternatively, many radiologists use a short axis diameter threshold of 10 mm for all sites with the exception of 15 mm for station 7. As normal nodes are often smaller, particularly in the upper paratracheal region, Glazer et al 4 have published specific threshold sizes for different mediastinal lymph node regions, which were used in the present study as limiting values for defining malignancy.
The finding of enlarged lymph nodes in patients with malignancy is usually interpreted as a sign of metastatic disease. 5 On the other hand, several recent studies have demonstrated that enlarged mediastinal lymph nodes are frequently observed in a lot of benign conditions like sarcoidosis, chronic heart failure, chronic obstructive pulmonary disease, and pneumoconiosis. [8] [9] [10] [11] [12] [13] [14] [15] Anthracosis is a form of pneumoconiosis which is caused by not only coal dust but also other environmental factors like air pollution, biomass fuels used extensively for cooking ("hut lung"), and cigarette smoke. [16] [17] [18] [19] [20] A recently published comparative study by our own study group in 44 heavy smokers and 44 non-smokers demonstrated that enlarged mediastinal lymph nodes may occur in a rather high percentage of heavy smokers, especially in those with severe bronchitis. 3 In that study, we found that lymph node enlargement in smokers may be caused by a deposition of anthracotic material and as a response to dust. In this context, one aim of the present comparative study between CT and EBUS-TBNA was to prove this hypothesis. To date, EBUS-TBNA is accepted as a safe and highly accurate procedure for the examination of hilar and mediastinal lymph nodes in patients with suspected lung malignancy. 7 In 2006, Herth et al 21 carried out a study in 100 patients to investigate the performance of EBUS-TBNA for staging lung cancer patients. In this study, the sensitivity and the negative predictive values for detecting malignancy were 92.3% and 96.3%, respectively. However, another comparative study, based on cytologically confirmed lymph nodes by means of EBUS-TBNA, revealed a lower sensitivity of 77% and a specificity of 55% for the CT-based diagnosis of lymph node involvement in lung cancer.
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Our CT findings indicate that anthracosis may often result in considerable enlargement of hilar and mediastinal lymph nodes measuring up to 23 mm in short axis diameter and 33 mm in long axis diameter. In our study, approximately 60% of all cytologically confirmed anthracotic lymph nodes were enlarged, whereas 40% were normal in size.
EBUS-TBNA revealed anthracotic lymph nodes in all ATS regions, with the exception of the regions 5, 6, and 8. Anthracotic lymph nodes were more frequently observed in regions 4R, 7, 10R, and 11R. It may be hypothesised that there is increased deposition of dust in these localisations.
Although the presence of enlarged, calcified mediastinal lymph nodes has been downright accepted as a common radiological finding in patients with coal worker's pneumoconiosis, [12] [13] [14] 23 calcification as an evidence of benignity was rarely observed in our patients (18%).
Egg-shell-like calcification due to the calcification of the periphery of lymph nodes, which has been reported in 56% of sandblasters suffering from silicosis, 13 was not identified in any of our patients.
The CT finding of a nodal confluence is frequently interpreted as a reliable indicator of malignancy.
24 Surprisingly, this finding was also identified in 28% of anthracotic lymph nodes in our patients. Central lucency as a sign of necrosis was not demonstrated in any of the anthracotic lymph nodes.
The results of the present study underscore the opinion that the diagnostic accuracy of the CT examination in distinguishing between malignant and benign lymph node enlargement is insufficient for making clinical decisions. 25 Unfortunately, several recent studies demonstrate that lymph node enlargement in pneumoconiosis may result in false-positive findings in 18F-fluorodeoxyglucose-PET/CT. [26] [27] [28] [29] Since neither mediastinoscopy nor extended mediastinoscopy are able to reach all lymph node stations, the evaluation of mediastinal lymph nodes remains a challenging diagnostic problem in these patients.
There were some limitations to our study. First, the sample size was small, preventing a generalisation of our results. Second, the study design was retrospective and we did not compare the findings of anthracotic lymph nodes with a sample of other benign enlarged lymph nodes (e.g. sarcoidosis). Therefore we consider our findings preliminary.
CONCLUSION
The findings of the present study confirm our hypothesis that anthracosis may often result in enlargement of hilar and mediastinal lymph nodes. Lymph nodes may show nodal confluence, but calcification is rarely observed. These findings seem to be of utmost importance, since anthracosis can mimic other more severe illnesses presenting with mediastinal lymphadenopathy.
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